Zenith BIO CEO & Investor Conference 2017Some great pick up and comments by fouremm, Bear, and nextblockbuster on Agora's Zenith discussion.
Fouremm noted that on page 3 of the Zenith presentation that the enterprise value of Zenith is now put at $500 million. Bear pointed out that it was $160 million in Dec 2016.
Poosible speculation from me is might this be related to the (Pfizer acquisition of one half enzalutimide - for $14 billion) and the zen3694 combined with enzalutimde trial that started dosing on mCRPC patients and might it suggest would could hear some positive results on the non enzalutimide phase which is now past 6 months for the longest dosed patient?
GLTA
Toinv